![Volume One: Metabolic Genomics & Pharmaceutics | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Volume One: Metabolic Genomics & Pharmaceutics | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://pharmaceuticalintelligence.com/wp-content/uploads/2015/03/sachs-flyer-2014-metabolomics-seriesdindividualred-page2.jpg)
Volume One: Metabolic Genomics & Pharmaceutics | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Structural characterization of the siderophore rhodochelin from Rhodococcus jostii RHA1 and elucidation of its biosynthetic mac
![PDF) TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma PDF) TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma](https://i1.rgstatic.net/publication/361630105_TRPM7_via_calcineurinNFAT_pathway_mediates_metastasis_and_chemotherapeutic_resistance_in_head_and_neck_squamous_cell_carcinoma/links/6332f07286b22d3db4e881bc/largepreview.png)
PDF) TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
![PDF) Treamid is a potential compound for inhibiting fibrosis and accelerating endothelial regeneration in idiopathic pulmonary fibrosis PDF) Treamid is a potential compound for inhibiting fibrosis and accelerating endothelial regeneration in idiopathic pulmonary fibrosis](https://i1.rgstatic.net/publication/349807618_Treamid_is_a_potential_compound_for_inhibiting_fibrosis_and_accelerating_endothelial_regeneration_in_idiopathic_pulmonary_fibrosis/links/6041ece54585154e8c780aa9/largepreview.png)